{
    "2019-10-11": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Progenics Pharmaceuticals Needs a Treatment for Sickly Corporate Governance",
                "features": {
                    "keywords": [
                        "Progenics",
                        "Pharmaceuticals",
                        "corporate governance"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals",
                "features": {
                    "keywords": [
                        "NVS",
                        "FDA nod",
                        "eye drug",
                        "NVO",
                        "GSK",
                        "PFE",
                        "deals"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}